Treatment of monomorphic B‐cell lymphoma with rituximab after liver transplantation in a child is a research paper published in Pediatric Transplantation (2003). On theSindex it has a DataRank of 0.982. It has been cited 16 times, with 16 citing works in its 1-hop citation network.
Abstract:Rituximab, a monoclonal antibody directed against the B‐cell specific CD20 antigen has been used with success in post‐transplant lymphoproliferative disorder (PTLD) of B‐cell phenotype. However, the use of such drug in children with liver transplantation and PTLD is very limited. We report a 2‐yr‐old liver transplant recipient with monomorphic non‐Hodgkin lymphoma of B‐cell origin. The lymphoma did not respond to immunosuppression withdrawal, with a subsequent allograft rejection. Despite resumption of immunosuppression and rejection treatment, the lymphoma was successfully treated with rituximab.
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.557
From 13 citing papers with measurable signal
DataRank blends this paper's own citation count with the influence of the papers that cite it. Here, roughly 43% comes from its base citations and 57% from the citation network (13 citing papers contributed measurable signal).
Citers are pulled from OpenAlex sorted by cited_by_count:descand capped per paper, so when the cap binds we keep the highest-signal references and the score is reproducible across reruns.
Click a node to highlight its connections. Use scroll to zoom. Drag to pan.